Terns Pharmaceuticals (TERN) Soars 24.41% on Bullish Sentiment

Terns Pharmaceuticals (TERN) surged 24.41% in pre-market trading on April 2, 2025, indicating a significant bullish sentiment among investors.

Terns Pharmaceuticals has a short interest of 5.95 million shares, representing 9.11% of the float. This high short interest suggests that a significant portion of the company's shares are being sold short, which could indicate bearish sentiment or speculative trading strategies.

The company's beta, as of March 31, 2025, is -1.70. A negative beta indicates that Terns Pharmaceuticals' stock price tends to move in the opposite direction of the overall market, suggesting that it may be a defensive stock during market downturns.